Health Care Tech

FDA approves marketing for new Alzheimer's early detection test

The Lumipulse G β-Amyloid Ratio (1-42/1-40) test is available at clinical laboratories nationwide for adult patients aged 55 years and older who are presenting with cognitive impairment and being evaluated for Alzheimer’s disease and other causes of cognitive decline.

Shanghai eases COVID lockdown in some areas

The Heritage Foundation Senior Fellow Brent Sadler discusses Shanghai's COVID lockdowns, China reportedly building up its nuclear efforts over rising fears of U.S. conflict and how the Biden administration should handle the Chinese government.